Browse by Person

Export as [feed] Atom [feed] RSS
Group by: Item Type | No Grouping
Number of items: 22.


Newell-Price, J., Huatan, H., Quirke, J. et al. (7 more authors) (2021) An oral lipidic native testosterone formulation that is absorbed independent of food. European Journal of Endocrinology, 185 (5). pp. 607-615. ISSN 0804-4643

Sims-Williams, H.P., Rajapaksa, K., Yianni, J. et al. (6 more authors) (2021) Long-term safety of gamma knife radiosurgery (SRS) for acromegaly. Pituitary. ISSN 1386-341X

Merke, D.P., Mallappa, A., Arlt, W. et al. (14 more authors) (2021) Modified-release hydrocortisone in congenital adrenal hyperplasia. The Journal of Clinical Endocrinology & Metabolism. dgab051. ISSN 0021-972X

Pivonello, R., Fleseriu, M., Newell-Price, J. et al. (14 more authors) (2020) Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3) : a multicentre phase III study with a doubleblind, randomised withdrawal phase. The Lancet Diabetes & Endocrinology. ISSN 2213-8587

Newell-Price, J., Nieman, L.K., Reincke, M. et al. (1 more author) (2020) Endocrinology in the time of COVID-19: Management of Cushing’s syndrome. European Journal of Endocrinology, 183 (1). G1-G7. ISSN 0804-4643

Newell-Price, J., Pivonello, R., Tabarin, A. et al. (9 more authors) (2020) Use of late-night salivary cortisol to monitor response to medical treatment in Cushing’s disease. European Journal of Endocrinology, 182 (2). pp. 207-217. ISSN 0804-4643

Harrison, R.F., Debono, M., Whitaker, M.J. et al. (3 more authors) (2018) Salivary cortisone to estimate cortisol exposure and sampling frequency required based on serum cortisol measurements. Journal of Clinical Endocrinology and Metabolism. ISSN 0021-972X

Daniel, E., Debono, M., Caunt, S. et al. (6 more authors) (2018) A prospective longitudinal study of Pasireotide in Nelson's syndrome. Pituitary.

Lacroix, A., Gu, F., Gallardo, W. et al. (12 more authors) (2017) Efficacy and safety of once-monthly pasireotide in Cushing's disease: A 12 month clinical trial. The Lancet Diabetes and Endocrinology. ISSN 2213-8587

Debono, M., Harrison, R.F., Chadarevian, R. et al. (3 more authors) (2017) Resetting the Abnormal Circadian Cortisol Rhythm in Adrenal Incidentaloma Patients With Mild Autonomous Cortisol Secretion. Journal of Clinical Endocrinology and Metabolism, 102 (9). pp. 3461-3469. ISSN 0021-972X

Daniel, E. and Newell-Price, J. (2017) Recent advances in understanding Cushing disease: resistance to glucocorticoid negative feedback and somatic USP8 mutations. F1000Research, 6. p. 613. ISSN 2046-1402

Daniel, E., Jones, R., Bull, M. et al. (1 more author) (2016) Rapid-sequence MRI for long-term surveillance for paraganglioma and phaeochromocytoma in patients with succinate dehydrogenase (SDHx) mutations. European Journal of Endocrinology , 175. pp. 561-570. ISSN 0804-4643

Speak, R., Cook, J., Harrison, B. et al. (1 more author) (2016) Disease-modifying polymorphisms and C609Y mutation of RET associated with high penetrance of phaeochromocytoma and low rate of MTC in MEN2A. Endocrinology, Diabetes and Metabolism Case Reports, 2016. EDM160093. ISSN 2052-0573

Jones, R., McDonald, K.E., Willson, J.A. et al. (15 more authors) (2016) Mutations in succinate dehydrogenase B (SDHB) enhance neutrophil survival independent of HIF-1α expression. Blood, 127 (21). pp. 2641-2644. ISSN 0006-4971

Findling, J.W., Fleseriu, M., Newell-Price, J. et al. (5 more authors) (2016) Late-night salivary cortisol may be valuable for assessing treatment response in patients with Cushing’s disease: 12-month, Phase III pasireotide study. Endocrine, 54 (2). pp. 516-523. ISSN 1355-008X

Daniel, E., Aylwin, S., Mustafa, O. et al. (25 more authors) (2015) Effectiveness of Metyrapone in Treating Cushing's Syndrome: A Retrospective Multicenter Study in 195 Patients. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 100 (11). pp. 4146-4154. ISSN 0021-972X

Wolin, E.M., Jarzab, B., Eriksson, B. et al. (16 more authors) (2015) Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues. Drug Design, Development and Therapy, 9. pp. 5075-5086. ISSN 1177-8881

Petersenn, S., Newell-Price, J., Findling, J. W. et al. (7 more authors) (2014) High variability in baseline urinary free cortisol values in patients with Cushing's disease. Clinical Endocrinology, 80 (2). pp. 261-269. ISSN 0300-0664

Debono, M., Chadarevian, R., Eastell, R. et al. (2 more authors) (2013) Mifepristone Reduces Insulin Resistance in Patient Volunteers with Adrenal Incidentalomas That Secrete Low Levels of Cortisol: A Pilot Study. PLOS ONE, 8 (4). ARTN e60984. ISSN 1932-6203

Debono, M., Ghobadi, C., Rostami-Hodjegan, A. et al. (7 more authors) (2009) Modified-release hydrocortisone to provide circadian cortisol profiles. Journal of Clinical Endocrinology and Metabolism, 94 (5). pp. 1548-1554. ISSN 0021-972X

Bevan, J. S., Newell-Price, J., Wass, J. A. H. et al. (8 more authors) (2008) Home administration of lanreotide Autogel (R) by patients with acromegaly, or their partners, is safe and effective. Clinical Endocrinology, 68 (3). pp. 343-349. ISSN 0300-0664

Conference or Workshop Item

Liyanarachchi, K., Amarawardena, M., Newell-Price, J. et al. (2 more authors) (2017) Pasireotide: successful treatment of a resistant case of Acromegaly. In: Society for Endocrinology Endocrine Update 2017.

This list was generated on Sat Dec 4 16:42:23 2021 GMT.